XLRN - Acceleron Pharma EPS misses by $0.04 misses on revenue November, 06 2019 07:56 AM Acceleron Pharma Inc. Acceleron Pharma (NASDAQ:XLRN): Q3 GAAP EPS of -$0.86 misses by $0.04.Revenue of $4.21M (+29.1% Y/Y) misses by $0.23M.Press ReleaseMore news on: Acceleron Pharma Inc., Earnings news and commentary, Healthcare stocks news,